March 20th 2023
Differences in baseline characteristics and eligible criteria in presymptomatic infants with spinal muscular atrophy led to differential results on motor and nonmotor clinical outcomes.
Novel Non-stimulant ADHD Treatments: A Review for Pharmacists
0.75 Credit / Neurology, Psychiatry
View More
The Promising Role of Novel and Emerging Therapies for Amyotrophic Lateral Sclerosis: Clinical and Managed Care Insights
View More
Managed Care Considerations for Parkinson Disease: A Focus on Recent Data and Emerging Therapies
1.0 Credit / Neurology
View More
A Focus on New Therapies for ADHD: Expanding Treatment Options for Patients (Pharmacy Technician Credit)
1.0 Credit / Neurology
View More
A Focus on New Therapies for ADHD: Expanding Treatment Options for Patients (Pharmacist Credit)
1.0 Credit / Neurology
View More
Treatment of ALS: Examining the Role of Current and Emerging Therapies
1.0 Credit / Neurology
View More
Treatment of Duchenne Muscular Dystrophy: Updates in Disease-Modifying Drugs
0.75 Credit / Neurology
View More
Therapeutic Strategies for Bipolar Disorder: Recognizing the Intricacies in Disease Management and Considerations for Pharmacists Across Practice Settings
2.0 Credits / Neurology, Psychiatry
View More
The Idea Behind Using Masked 40 Hz, Light Based Brain Stimulation for Alzheimer Disease
March 16th 2023Marcus Carstensen, PhD candidate, CTO and co-founder of OptoCeutics in Copenhagen, Denmark, talked about the mechanisms of using noninvasive light technologies for Alzheimer disease treatment.
Using MRIs to Detect Early Signs of Viral Infections in Multiple Sclerosis
March 16th 2023At the 2023 ACTRIMS forum, Omar Al-Louzi, MD, director of the Visual Outcomes Laboratory at Cedars Sinai, talked about investigating the relationship between viral infections and multiple sclerosis using MRIs.
NeurologyLive® Top Expert Interviews: National Sleep Awareness Week
March 15th 2023In honor of National Sleep Awareness Week, a group of experts in the care of patients with sleep disorders—Wendy Troxel, PhD; Garth Whiteside; Milena Pavlova, MD; Ronald Gavidia, MD, MS; Renee Shellhaas, MD, MS, FAES—shared their perspectives on hot topics of treatment and management in sleep medicine.
Applying Artificial Intelligence to Monitor Multiple Sclerosis Disease Progression
Michael Dwyer, PhD, director of IT and Neuroinformatics Development at the Buffalo Neuroimaging Analysis Center, provided insight on how artificial intelligence techniques may be used to monitor disease progression in multiple sclerosis.
Trofinetide Approval Brings Encouragement for Rett Disease, Rare Neurodevelopmental Disorders
March 14th 2023Jeffery Neul, MD, PhD, director of the Vanderbilt Kennedy Center, and professor of pediatrics at Vanderbilt University Medical Center, shared his reactions and thoughts to the approval of trofinetide.
NeurologyLive® Top Expert Interviews: Brain Awareness Week
March 14th 2023In honor of Brain Awareness Week, a group of experts in the care of patients with neurological conditions—Ronald C. Petersen, MD, PhD; Brian Grosberg, MD, FAHS; James Beck, PhD; Michael Levy, MD, PhD; Stanley H. Appel, MD —shared their perspectives on hot topics of treatment and management in neurology.
Narcolepsy Causes Significant Impact on Social Relationship Health in Adolescents, Study Shows
March 14th 2023Published findings showed that narcolepsy has a significant impact on social relationships in adolescents, thus suggesting that structured routine for assessing social health is a vital first step for treatment.
Cognitive and Functional Differences Identified in Parkinson Disease Prior to Diagnosis
Findings showed that global cognition declines in the prediagnostic period in men but not women with incident Parkinson disease, further indicating cognitive heterogeneity in the prodromal period by sex.
Global Access to Mechanical Thrombectomy Significantly Low, Study Suggests
Among countries with non-zero mechanical thrombectomy access, there was a 460-fold difference in availability of this care between the country with the highest and lowest access rate reported.